Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma
Author:
Affiliation:
1. Center for Hematologic Malignancies, Oregon Health & Science University, Portland, OR, USA;
2. Cancer Research and Biostatistics, Seattle, WA, USA;
3. Department of Pathology, Oregon Health & Science University, Portland, OR, USA
Publisher
Informa UK Limited
Subject
Cancer Research,Oncology,Hematology
Link
https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1406085
Reference15 articles.
1. Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas
2. Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements
3. Double-hit B-cell lymphomas
4. The 2016 revision of the World Health Organization classification of lymphoid neoplasms
5. Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Extranodal diffuse large B-cell lymphoma presenting with extensive organ involvement;BMJ Case Reports;2024-06
2. Induction treatment in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: a systematic review and meta-analysis;Frontiers in Oncology;2023-07-20
3. CD19/CD22 chimeric antigen receptor (CAR) T-cell cocktail therapy following autologous transplantation in patients with relapsed/refractory diffuse large B-cell lymphoma on 18F-FDG PET/CT: a case description;Quantitative Imaging in Medicine and Surgery;2023-07
4. Strategies for Targeting MYC;Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies;2023-03-15
5. Favorable Outcomes with R-CHOP Induction and Consolidative Autologous Stem Cell Transplantation for Double-Hit Lymphoma;Transplantation and Cellular Therapy;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3